Published in Clin Infect Dis on October 16, 2012
Antibiotics Continuous Infusion at Home (TAID) | NCT04816968
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis (2016) 2.32
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (2013) 1.85
Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care (2015) 1.30
Are prolonged/continuous infusions of β-lactams for all? Clin Infect Dis (2013) 1.28
Antibiotic stewardship in the intensive care unit. Crit Care (2014) 1.18
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2013) 0.96
Is extended or continuous infusion of carbapenems the obvious solution to improve clinical outcomes and reduce mortality? Clin Infect Dis (2013) 0.96
Aerosolized antibiotics: do they add to the treatment of pneumonia? Curr Opin Infect Dis (2013) 0.89
Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy? Expert Opin Pharmacother (2016) 0.89
Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014. Antimicrob Agents Chemother (2017) 0.86
Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis. Crit Care (2013) 0.83
Treatment of bloodstream infections in ICUs. BMC Infect Dis (2014) 0.82
Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center. Antimicrob Agents Chemother (2014) 0.81
continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis. PLoS One (2013) 0.81
Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. Curr Infect Dis Rep (2015) 0.81
Antibiotics for the critically ill: more than just selecting appropriate initial therapy. Crit Care (2013) 0.80
High-dose continuous oxacillin infusion results in achievement of pharmacokinetics targets in critically ill patients with deep sternal wound infections following cardiac surgery. Antimicrob Agents Chemother (2014) 0.78
Bloodstream infections in the Intensive Care Unit. Virulence (2016) 0.78
Osteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: The first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada. Can J Infect Dis Med Microbiol (2014) 0.78
Optimizing antimicrobial therapy in critically ill patients. Infect Drug Resist (2014) 0.77
Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta-Analysis. Infect Chemother (2016) 0.76
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev (2017) 0.76
Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis. PLoS One (2015) 0.76
Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory. Clin Microbiol Rev (2016) 0.75
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing. Clin Ther (2016) 0.75
Is there a role for continuous infusion of β-lactam antibiotics in severe sepsis? J Thorac Dis (2016) 0.75
Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model. Antimicrob Agents Chemother (2014) 0.75
Outcomes in Documented Pseudomonas aeruginosa Bacteremia Treated with Intermittent IV Infusion of Ceftazidime, Meropenem, or Piperacillin-Tazobactam: A Retrospective Study. Can J Hosp Pharm (2015) 0.75
Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae. Antibiotics (Basel) (2015) 0.75
Reply to Soman et al and Frippiat et al. Clin Infect Dis (2013) 0.75
Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device. Case Rep Infect Dis (2017) 0.75
Influence of beta-lactam infusion strategy on acute kidney injury. Antimicrob Agents Chemother (2017) 0.75
[Intensive care studies from 2015/2016]. Anaesthesist (2016) 0.75
Serum concentrations of amoxicillin in neonates during continuous intravenous infusion. Eur J Clin Microbiol Infect Dis (2016) 0.75
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis (2014) 2.29
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 2.01
Sex differences in the incidence and severity of respiratory tract infections. Respir Med (2007) 1.99
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (2013) 1.85
Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis (2005) 1.74
Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis (2010) 1.72
Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med (2007) 1.50
Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction. Int J Antimicrob Agents (2010) 1.13
Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review. Eur J Pharmacol (2006) 1.12
Outcome of critically ill oldest-old patients (aged 90 and older) admitted to the intensive care unit. J Am Geriatr Soc (2006) 1.04
Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother (2008) 1.03
Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2008) 1.01
Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Lancet Infect Dis (2008) 1.01
Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence. J Antimicrob Chemother (2007) 0.99
Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother (2006) 0.97
Linezolid for the treatment of adults with bone and joint infections. Int J Antimicrob Agents (2007) 0.96
Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: a prospective study. Future Microbiol (2013) 0.95
Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes. Int J Antimicrob Agents (2009) 0.94
Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis. Shock (2010) 0.93
Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis. PLoS One (2012) 0.91
Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. Int J Antimicrob Agents (2012) 0.90
A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer (2013) 0.90
An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication. J Infect Chemother (2010) 0.89
Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. Drug Saf (2008) 0.89
Renal function as a predictor of linezolid-induced thrombocytopenia. Int J Antimicrob Agents (2008) 0.87
Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review. Expert Rev Anti Infect Ther (2013) 0.87
Risk factors for ganciclovir-induced thrombocytopenia and leukopenia. Biol Pharm Bull (2015) 0.87
Open access World Wide Web resources on urogenital infections. Nephrol Dial Transplant (2007) 0.86
β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. Int J Antimicrob Agents (2013) 0.86
Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis. Antimicrob Agents Chemother (2012) 0.85
The pharmacokinetics of low-dose thalidomide in Japanese patients with refractory multiple myeloma. Biol Pharm Bull (2006) 0.84
Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis. J Neurosurg (2015) 0.84
Evaluation of the efficacy and safety of biapenem against pneumonia in the elderly and a study on its pharmacokinetics. J Infect Chemother (2012) 0.83
Fluoroquinolones vs beta-lactams for empirical treatment of immunocompetent patients with skin and soft tissue infections: a meta-analysis of randomized controlled trials. Mayo Clin Proc (2006) 0.83
Quantification of doripenem in human plasma and peritoneal fluid by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.82
Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections. J Infect Chemother (2010) 0.82
Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine. Dig Dis Sci (2006) 0.82
Effectiveness and safety of tigecycline: focus on use for approved indications. Clin Infect Dis (2012) 0.82
continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis. PLoS One (2013) 0.81
Use of negative-pressure wound therapy in breast tissues: evaluation of the literature. Surg Infect (Larchmt) (2014) 0.81
Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia. Int J Antimicrob Agents (2011) 0.81
Real-time therapeutic drug monitoring of cefozopran in plasma using high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal (2007) 0.80
High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.80
Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves. J Infect Chemother (2011) 0.80
Determination of total cefozopran concentrations in human peritoneal fluid by HPLC with cefepime as an internal standard: Comparative pharmacokinetics in the fluid and plasma. J Pharm Biomed Anal (2009) 0.79
HPLC method for measuring meropenem and biapenem concentrations in human peritoneal fluid and bile: application to comparative pharmacokinetic investigations. J Chromatogr Sci (2010) 0.79
Pharmacokinetics and pharmacodynamics of biapenem in critically ill patients under continuous venovenous hemodiafiltration. Jpn J Antibiot (2008) 0.78
Gas chromatography-electron ionization-mass spectrometry quantitation of valproic acid and gabapentin, using dried plasma spots, for therapeutic drug monitoring in in-home medical care. Biomed Chromatogr (2014) 0.78
Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients. Int J Antimicrob Agents (2010) 0.78
Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis. Expert Rev Anti Infect Ther (2013) 0.78
Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia. Biol Pharm Bull (2014) 0.78
Impact of vacuum-assisted closure (VAC) therapy on clinical outcomes of patients with sternal wound infections: a meta-analysis of non-randomized studies. PLoS One (2013) 0.77
Pharmacokinetics and pharmacodynamics of biapenem in human cerebrospinal fluid. Int J Antimicrob Agents (2009) 0.77
Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data. Int J Antimicrob Agents (2012) 0.77
Interpretation of the findings of a cohort study of bacteremic patients with community-acquired pneumonia. Chest (2007) 0.77
Development of initial loading procedure for teicoplanin in critically ill patients with severe infections. Biol Pharm Bull (2013) 0.77
[In vitro combined effects of double antibacterial drugs against multidrug-resistant Pseudomonas aeruginosa isolates: comparison among combinations of colistin, arbekacin, aztreonam, rifampicin and piperacillin]. Jpn J Antibiot (2014) 0.76
[Arbekacin sulfate concentrations in peripheral lymph and in serum after intravenous injection: report of four cases]. Jpn J Antibiot (2012) 0.76
Decreasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials. Curr Med Res Opin (2008) 0.76
Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children. Pediatr Infect Dis J (2013) 0.76
Reply to Soman et al and Frippiat et al. Clin Infect Dis (2013) 0.75
Ventilator-associated sinusitis in adults: systematic review and meta-analysis. Respir Med (2012) 0.75
Trends of mortality due to septicemia in Greece: an 8-year analysis. PLoS One (2013) 0.75
Understanding of statistical terms routinely used in meta-analyses: an international survey among researchers. PLoS One (2013) 0.75
Development and validation of a GC-EI-MS method with reduced adsorption loss for the quantification of olanzapine in human plasma. Anal Bioanal Chem (2012) 0.75
A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75
Pharmacokinetics of ampicillin-sulbactam and the renal function-based optimization of dosing regimens for prophylaxis in patients undergoing cardiovascular surgery. J Infect Chemother (2012) 0.75
Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation. Int J Antimicrob Agents (2013) 0.75
Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment. J Infect Chemother (2008) 0.75
Factors affecting treatment and recurrence of Clostridium difficile infections. Biol Pharm Bull (2014) 0.75
Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass. Biol Pharm Bull (2015) 0.75
Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen. Int J Clin Pharmacol Ther (2015) 0.75
[Dosing regimen rationalization of biapenem in pediatric patients: use of Monte Carlo simulation]. Jpn J Antibiot (2009) 0.75
Vacuum-assisted closure versus closure without vacuum assistance for preventing surgical site infections and infections of chronic wounds: a meta-analysis of randomized controlled trials. Surg Infect (Larchmt) (2014) 0.75
Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis. J Antimicrob Chemother (2008) 0.75
Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients. Am J Hematol (2006) 0.75
Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic-pharmacodynamic evaluation. J Chemother (2012) 0.75
Population Pharmacokinetic Analysis and Pharmacodynamic Evaluation of Ampicillin-sulbactam in Pediatric Patients Using Plasma and Urine Data. Pediatr Infect Dis J (2022) 0.75
Pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in the bile of patients undergoing biliary pancreatic surgery. J Chemother (2014) 0.75
Considerations of meropenem dosage for bacterial meningitis based on pharmacodynamics in cerebrospinal fluid. Int J Antimicrob Agents (2008) 0.75
Effects of domperidone on human plasma levels of motilin, somatostatin, gastrin, adrenocorticotropic hormone and cortisol. Biol Pharm Bull (2005) 0.75